These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35394722)

  • 1. [Anxiety-depressive disorders and stress factors in patients with systemic lupus erythematosus and antiphospholipid syndrome].
    Borisova AB; Veltishchev DY; Lisitsyna TA; Reshetnyak TM; Seravina OF; Kovalevskaya OB; Cheldieva FA; Abramkin AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(3):65-71. PubMed ID: 35394722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mental disorders in patients with systemic lupus erythematosus: association with activity and the course of rheumatic disease].
    Borisova AB; Lisitsyna TA; Veltishchev DY; Reshetnyak TM
    Ter Arkh; 2023 Jul; 95(5):392-397. PubMed ID: 38158990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid syndrome damage index (DIAPS): distinct long-term kinetic in primary antiphospholipid syndrome and antiphospholipid syndrome related to systemic lupus erythematosus.
    Torricelli AK; Ugolini-Lopes MR; Bonfá E; Andrade D
    Lupus; 2020 Mar; 29(3):256-262. PubMed ID: 31986962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systemic lupus erythematosus and antiphospholipid syndrome - diagnostic and therapeutic problems].
    Zdrojewski Z
    Wiad Lek; 2018; 71(1 pt 1):40-46. PubMed ID: 29558350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality.
    Riancho-Zarrabeitia L; Martínez-Taboada V; Rúa-Figueroa I; Alonso F; Galindo-Izquierdo M; Ovalles J; Olivé-Marqués A; Fernández-Nebro A; Calvo-Alén J; Menor-Almagro R; Tomero-Muriel E; Uriarte-Isacelaya E; Botenau A; Andres M; Freire-González M; Santos Soler G; Ruiz-Lucea E; Ibáñez-Barceló M; Castellví I; Galisteo C; Quevedo Vila V; Raya E; Narváez-García J; Expósito L; Hernández-Beriaín JA; Horcada L; Aurrecoechea E; Pego-Reigosa JM
    Lupus; 2020 Oct; 29(12):1556-1565. PubMed ID: 32807021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and pattern of antiphospholipid antibody syndrome in a hospital based longitudinal study of 193 patients of systemic lupus erythematosus.
    Singh NK; Agrawal A; Singh MN; Kumar V; Godhra M; Gupta A; Yadav DP; Usha ; Singh RG; Singh TB
    J Assoc Physicians India; 2013 Sep; 61(9):623-6. PubMed ID: 24772699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies and clinical features of the antiphospholipid syndrome as criteria for systemic lupus erythematosus.
    Merrill JT
    Lupus; 2004; 13(11):869-76. PubMed ID: 15580985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical spectrum of males with primary antiphospholipid syndrome and systemic lupus erythematosus: a comparative study of 73 patients.
    Medina G; Vera-Lastra O; Barile L; Salas M; Jara LJ
    Lupus; 2004; 13(1):11-6. PubMed ID: 14870912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus.
    Tarr T; Lakos G; Bhattoa HP; Szegedi G; Shoenfeld Y; Kiss E
    Lupus; 2007; 16(5):324-8. PubMed ID: 17576733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avoiding misclassification of thrombotic primary antiphospholipid syndrome as systemic lupus erythematosus (SLE): What are the best-performing SLE classification criteria?
    Signorelli F; Balbi GGM; Bonfá E; Borba EF; Andrade DCO
    Lupus; 2021 Oct; 30(11):1732-1738. PubMed ID: 34292093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct antibody profile: a clue to primary antiphospholipid syndrome evolving into systemic lupus erythematosus?
    Freire PV; Watanabe E; dos Santos NR; Bueno C; Bonfá E; de Carvalho JF
    Clin Rheumatol; 2014 Mar; 33(3):349-53. PubMed ID: 24420722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markers of NETosis in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome.
    Reshetnyak T; Nurbaeva K; Ptashnik I; Kudriaeva A; Belogurov A; Lila A; Nasonov E
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac dysfunction in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Paran D; Caspi D; Levartovsky D; Elkayam O; Kaufman I; Litinsky I; Keren G; Koifman B
    Ann Rheum Dis; 2007 Apr; 66(4):506-10. PubMed ID: 17079247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thin-section chest CT findings in systemic lupus erythematosus with antiphospholipid syndrome: a comparison with systemic lupus erythematosus without antiphospholipid syndrome.
    Oki H; Aoki T; Saito K; Yamashita Y; Hanamiya M; Hayashida Y; Tanaka Y; Korogi Y
    Eur J Radiol; 2012 Jun; 81(6):1335-9. PubMed ID: 21501937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcranial Doppler findings in antiphospholipid syndrome.
    Ricarte IF; Dutra LA; Barsottini OGP; Souza AWS; Andrade DCO; Mangueira C; Silva GS
    Lupus; 2019 Apr; 28(4):483-491. PubMed ID: 30755144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and morphological characteristics of lupus nephritis in systemic lupus erythematosus with antiphospholipid syndrome].
    Kozlovskaia NL; Shilov EM; Meteleva NA; Varshavskiĭ VA; Miroshnichenko NG; Samokishina NA; Serova AG; Nesterova SG
    Ter Arkh; 2006; 78(5):21-31. PubMed ID: 16889045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-thromboembolic risk in systemic lupus erythematosus associated with antiphospholipid syndrome.
    Deák M; Bocskai M; Burcsár S; Dányi O; Fekete Z; Kovács L
    Lupus; 2014 Aug; 23(9):913-8. PubMed ID: 24729279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus.
    Perez-Sanchez C; Barbarroja N; Messineo S; Ruiz-Limon P; Rodriguez-Ariza A; Jimenez-Gomez Y; Khamashta MA; Collantes-Estevez E; Cuadrado MJ; Aguirre MA; Lopez-Pedrera C
    Ann Rheum Dis; 2015 Jul; 74(7):1441-9. PubMed ID: 24618261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.